Genotypic analysis of Acinetobacter bloodstream infection isolates in a Turkish university hospital

被引:33
作者
Alp, E [1 ]
Esel, D
Yildiz, O
Voss, A
Melchers, W
Doganay, M
机构
[1] Erciyes Univ, Fac Med, Dept Infect Dis, TR-38039 Kayseri, Turkey
[2] Radboud Univ, Nijmegen Med Ctr, Nijmegen, Netherlands
[3] Univ Nijmegen, Ctr Infect, Nijmegen, Netherlands
[4] Canisus Wilhelmina Hosp, Nijmegen, Netherlands
关键词
D O I
10.1080/00365540500488907
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Acinetobacter baumannii is a significant pathogen of bloodstream infections in hospital patients that frequently causes single clone outbreaks. We aimed to evaluate the genetic relatedness and antimicrobial susceptibility of Acinetobacter spp. bloodstream isolates, in order to obtain insight into their cross-transmission. This prospective study was conducted at the Erciyes University Hospital. During a 1-y period, all patients with nosocomial BSI caused by Acinetobacter spp. were included in the study. All data with regard to the patients, underlying diseases and risk factors for BSI and the severity of disease were collected. Blood culture isolates of Acinetobacter spp. were identified according to their morphology and biochemical reactions. The antimicrobial susceptibility was determined using the Kirby-Bauer disk diffusion test according to the NCCLS; the genetic relatedness of isolates was determined by RAPD-PCR analysis and pulsed-field gel electrophoresis (PFGE). 41 patients acquired a nosocomial bloodstream infection caused by A. baumanii during this period. 88% of these infections ( 36 of 41) occurred while the patients were treated in the intensive care unit. Nearly 80% of the isolates belonged to 3 genotypes, suggesting cross-transmission in ICU settings where infection control practices are poor. All Acinetobacter isolates were multidrug-resistant and the crude mortality of patients infected with A. baumanii was 80.5%. We concluded that the genetic relatedness of Acinetobacter spp. causing BSI was very high, indicating cross-transmission within the ICU setting. Essential components of an infection control programme to prevent nosocomial transmission of A. baumannii are early detection of colonized patients, followed by strict attention to standard precautions and contact isolation.
引用
收藏
页码:335 / 340
页数:6
相关论文
共 34 条
  • [1] DNA DIVERSITY AMONG CLINICAL ISOLATES OF HELICOBACTER-PYLORI DETECTED BY PCR-BASED RAPD FINGERPRINTING
    AKOPYANZ, N
    BUKANOV, NO
    WESTBLOM, TU
    KRESOVICH, S
    BERG, DE
    [J]. NUCLEIC ACIDS RESEARCH, 1992, 20 (19) : 5137 - 5142
  • [2] Bacteriological, clinical and epidemiological characteristics of hospital-acquired Acinetobacter baumannii infection in a teaching hospital
    Ayan, M
    Durmaz, R
    Aktas, E
    Durmaz, B
    [J]. JOURNAL OF HOSPITAL INFECTION, 2003, 54 (01) : 39 - 45
  • [3] Implications for Burns Unit design following outbreak of multi-resistant Acinetobacter infection in ICU and Burns Unit
    Bayat, A
    Shaaban, H
    Dodgson, A
    Dunn, KW
    [J]. BURNS, 2003, 29 (04) : 303 - 306
  • [4] Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients:: a matched cohort study
    Blot, S
    Vandewoude, K
    Colardyn, F
    [J]. INTENSIVE CARE MEDICINE, 2003, 29 (03) : 471 - 475
  • [5] AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    ABRAMS, JH
    BERNARD, GR
    BIONDI, JW
    CALVIN, JE
    DEMLING, R
    FAHEY, PJ
    FISHER, CJ
    FRANKLIN, C
    GORELICK, KJ
    KELLEY, MA
    MAKI, DG
    MARSHALL, JC
    MERRILL, WW
    PRIBBLE, JP
    RACKOW, EC
    RODELL, TC
    SHEAGREN, JN
    SILVER, M
    SPRUNG, CL
    STRAUBE, RC
    TOBIN, MJ
    TRENHOLME, GM
    WAGNER, DP
    WEBB, CD
    WHERRY, JC
    WIEDEMANN, HP
    WORTEL, CH
    [J]. CRITICAL CARE MEDICINE, 1992, 20 (06) : 864 - 874
  • [6] BOUZA E, 1999, CLIN MICROBIOL INFEC, V5, P1
  • [7] A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION
    CHARLSON, ME
    POMPEI, P
    ALES, KL
    MACKENZIE, CR
    [J]. JOURNAL OF CHRONIC DISEASES, 1987, 40 (05): : 373 - 383
  • [8] Nosocomial bacteremia due to Acinetobacter baumannii:: epidemiology, clinical features and treatment
    Cisneros, JM
    Rodríguez-Baño, J
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2002, 8 (11) : 687 - 693
  • [9] Problems and solutions in hospital-acquired bacteraemia
    Correa, L
    Pittet, D
    [J]. JOURNAL OF HOSPITAL INFECTION, 2000, 46 (02) : 89 - 95
  • [10] Use of interrepeat PCR fingerprinting to investigate an Acinetobacter baumannii outbreak in an intensive care unit
    Debast, SB
    Meis, JFGM
    Melchers, WJG
    HoogkampKorstanje, JAA
    Voss, A
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1996, 28 (06) : 577 - 581